VSTM Insider Trading
Verastem, Inc. | Pharmaceutical Preparations
Comprehensive Trading Performance Summary
The investment history of corporate insiders at Verastem, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Pharmaceutical Preparations sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2022-05-17 23:07 | 2022-05-16 | Stuglik Brian M | Director, Officer - Chief Executive Officer | SELL | $1.03 | 13,794 | $14,208 | 1,163,813 | -1.2% |
| 2022-05-17 23:05 | 2022-05-16 | Gagnon Robert E. | Officer - Chief Financial Officer | SELL | $1.03 | 16,627 | $17,126 | 591,253 | -2.7% |
| 2022-05-04 23:00 | 2022-05-02 | Stuglik Brian M | Director, Officer - Chief Executive Officer | SELL | $1.41 | 5,857 | $8,258 | 1,127,607 | -0.5% |
| 2022-03-23 23:02 | 2022-03-21 | Paterson Dan | Officer - President and COO | SELL | $1.27 | 2,818 | $3,579 | 477,933 | -0.6% |
| 2022-03-23 23:01 | 2022-03-21 | Stuglik Brian M | Director, Officer - Chief Executive Officer | SELL | $1.27 | 3,507 | $4,454 | 1,133,464 | -0.3% |
| 2022-03-23 23:01 | 2022-03-21 | Gagnon Robert E. | Officer - Chief Financial Officer | SELL | $1.27 | 1,409 | $1,789 | 557,880 | -0.3% |
| 2022-02-03 00:05 | 2022-01-31 | Stuglik Brian M | Director, Officer - Chief Executive Officer | SELL | $1.48 | 5,695 | $8,429 | 1,136,971 | -0.5% |
| 2022-01-06 00:03 | 2022-01-03 | Stuglik Brian M | Director, Officer - Chief Executive Officer | SELL | $2.05 | 26,033 | $53,368 | 1,142,666 | -2.2% |
| 2022-01-06 00:01 | 2022-01-03 | Paterson Dan | Officer - President and COO | SELL | $2.05 | 23,534 | $48,245 | 480,751 | -4.7% |
| 2022-01-06 00:02 | 2022-01-03 | Gagnon Robert E. | Officer - Chief Financial Officer | SELL | $2.05 | 19,612 | $40,205 | 559,289 | -3.4% |
| 2021-12-23 00:02 | 2021-12-20 | Stuglik Brian M | Director, Officer - Chief Executive Officer | SELL | $2.27 | 13,682 | $31,058 | 1,168,699 | -1.2% |
| 2021-12-23 00:01 | 2021-12-20 | Paterson Dan | Officer - President and COO | SELL | $2.27 | 10,994 | $24,956 | 504,285 | -2.1% |
| 2021-12-23 00:01 | 2021-12-20 | Gagnon Robert E. | Officer - Chief Financial Officer | SELL | $2.27 | 5,497 | $12,478 | 578,901 | -0.9% |
| 2020-12-07 19:15 | 2020-12-04 | BARBERICH TIMOTHY J | Director | BUY | $2.17 | 50,000 | $108,500 | 218,000 | +29.8% |
| 2020-06-30 01:29 | 2020-06-25 | RA CAPITAL MANAGEMENT, L.P. | 10% owner | SELL | $1.91 | 1,161,300 | $2,219,941 | 16,142,051 | -6.7% |
| 2020-04-29 23:30 | 2020-04-27 | RA CAPITAL MANAGEMENT, L.P. | 10% owner | SELL | $2.31 | 1,301,300 | $3,002,099 | 17,303,351 | -7.0% |
| 2019-03-19 23:12 | 2019-03-15 | BARBERICH TIMOTHY J | Director | BUY | $3.21 | 33,000 | $105,930 | 168,000 | +24.4% |
| 2018-10-03 02:11 | 2018-09-28 | Lobacki Joseph M | Officer - Executive VP & CCO | BUY | $7.30 | 3,000 | $21,900 | 10,700 | +39.0% |
| 2018-10-03 01:58 | 2018-09-28 | Paterson Dan | Officer - Chief Operating Officer | BUY | $7.00 | 3,000 | $21,000 | 23,286 | +14.8% |
| 2018-10-03 01:42 | 2018-09-28 | Stuglik Brian M | Director | BUY | $7.30 | 1,000 | $7,303 | 1,000 | +100.0% |
| 2018-10-03 01:49 | 2018-09-28 | Kauffman Michael | Director | BUY | $7.49 | 4,000 | $29,960 | 4,000 | +100.0% |
| 2018-10-03 01:52 | 2018-09-28 | Forrester Robert | Director, Officer - President and CEO | BUY | $7.00 | 2,000 | $14,000 | 221,234 | +0.9% |
| 2018-10-03 02:16 | 2018-09-28 | BARBERICH TIMOTHY J | Director | BUY | $7.31 | 5,000 | $36,550 | 135,000 | +3.8% |
| 2018-10-02 01:35 | 2018-09-27 | Paterson Dan | Officer - Chief Operating Officer | BUY | $7.03 | 2,000 | $14,056 | 20,286 | +10.9% |
| 2018-10-02 01:39 | 2018-09-27 | Forrester Robert | Director, Officer - President and CEO | BUY | $7.00 | 10,500 | $73,500 | 219,234 | +5.0% |
| 2018-06-13 01:58 | 2018-06-08 | Lobacki Joseph M | Officer - Executive VP & CCO | BUY | $5.79 | 7,700 | $44,583 | 7,700 | +100.0% |
| 2018-06-13 01:58 | 2018-06-08 | Bloom Steven H. | Officer - Chief Strategy Officer | BUY | $5.98 | 3,000 | $17,940 | 3,500 | +600.0% |
| 2017-12-08 00:02 | 2017-12-05 | BARBERICH TIMOTHY J | Director | BUY | $3.95 | 60,538 | $239,125 | 130,000 | +87.2% |
| 2017-05-17 15:21 | 2017-05-15 | BARBERICH TIMOTHY J | Director | BUY | $2.45 | 30,000 | $73,500 | 69,462 | +76.0% |
| 2016-02-18 01:00 | 2015-03-19 | Kauffman Michael | Director | SELL | $7.86 | 3,000 | $23,566 | 0 | -100.0% |
| 2015-06-30 15:41 | 2015-06-29 | Singh Monica | Officer - General Counsel | BUY | $6.95 | 1,000 | $6,950 | 2,000 | +100.0% |
| 2015-06-30 15:41 | 2015-06-29 | Forrester Robert | Director, Officer - President and CEO | BUY | $7.11 | 2,000 | $14,210 | 226,924 | +0.9% |
| 2015-06-30 15:41 | 2015-06-29 | GREEN JOHN B | Officer - Chief Financial Officer | BUY | $7.12 | 500 | $3,560 | 2,500 | +25.0% |
| 2015-06-29 15:08 | 2015-06-26 | GREEN JOHN B | Officer - Chief Financial Officer | BUY | $7.39 | 500 | $3,696 | 2,000 | +33.3% |
| 2015-06-22 15:49 | 2015-06-18 | Paterson Dan | Officer - Chief Operating Officer | BUY | $8.05 | 1,000 | $8,045 | 32,571 | +3.2% |
| 2015-06-18 21:32 | 2015-06-17 | Forrester Robert | Director, Officer - President and CEO | BUY | $7.97 | 1,000 | $7,970 | 224,924 | +0.4% |
| 2015-01-28 22:16 | 2015-01-28 | Westphal Christoph H | Director, Officer - Executive Chairman | BUY | $6.50 | 1,230,769 | $7,999,999 | 1,230,769 | +100.0% |
| 2015-01-28 22:17 | 2015-01-28 | BARBERICH TIMOTHY J | Director | BUY | $6.50 | 38,462 | $250,003 | 39,462 | +3,846.2% |
| 2015-01-07 17:48 | 2014-12-23 | TERMEER HENRI A | Director | BUY | $8.11 | 29,000 | $235,135 | 14,000 | +100.0% |
| 2014-12-31 20:20 | 2014-12-29 | Horobin Joanna | Officer - Chief Medical Officer | BUY | $8.60 | 750 | $6,450 | 750 | +100.0% |
| 2014-12-31 20:20 | 2014-12-29 | Phanstiel S. Louise | Director | BUY | $8.54 | 10,000 | $85,435 | 26,500 | +60.6% |
| 2014-12-29 17:45 | 2014-12-24 | FRIEDMAN PAUL A | Director | BUY | $8.31 | 3,000 | $24,932 | 3,000 | +100.0% |
| 2014-12-29 17:45 | 2014-12-26 | SHERWIN STEPHEN A | Director | BUY | $8.56 | 2,500 | $21,395 | 2,500 | +100.0% |
| 2014-12-24 19:09 | 2014-12-23 | TERMEER HENRI A | Director | BUY | $8.09 | 19,100 | $154,546 | 10,100 | +100.0% |
| 2014-12-24 00:56 | 2014-12-23 | Singh Monica | Officer - General Counsel | BUY | $8.09 | 1,000 | $8,089 | 1,000 | +100.0% |
| 2014-12-24 00:57 | 2014-12-23 | GREEN JOHN B | Officer - Chief Financial Officer | BUY | $8.17 | 500 | $4,085 | 1,500 | +50.0% |
| 2014-12-22 18:33 | 2014-12-19 | Paterson Dan | Officer - Chief Operating Officer | BUY | $8.52 | 2,000 | $17,040 | 45,857 | +4.6% |
| 2014-12-22 18:50 | 2014-12-19 | Westphal Christoph H | Director, Officer - Executive Chairman | BUY | $8.50 | 1,500 | $12,750 | 687,016 | +0.2% |
| 2014-12-19 21:29 | 2014-12-19 | Forrester Robert | Director, Officer - President and CEO | BUY | $8.66 | 1,000 | $8,660 | 232,114 | +0.4% |
| 2014-11-12 22:58 | 2014-11-11 | Lawton Alison Frances | Director | BUY | $9.17 | 2,500 | $22,923 | 2,500 | +100.0% |
How to Interpret $VSTM Trades
Not every insider transaction in Verastem, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $VSTM shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for VSTM
Insider activity data for Verastem, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $VSTM, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.